Home/About HealthSignals

About

HealthSignals is a healthcare intelligence publication covering pharma, payer systems, regulatory policy, and health technology across Latin America and the United States. We write for executives, investors, payers, and policy stakeholders who need precise reading of structural shifts in the sector — not surface coverage of press releases.

What we cover

Six verticals across two regions, one institutional voice. Regulatory decisions from ANVISA, ANS, CONITEC, COFEPRIS, INVIMA, ANMAT, ISP, FDA, and CMS. Payer reform, hospital consolidation, drug pricing, market access, and clinical catalysts. We prioritise signals that change capital allocation, reimbursement, or patient access — and we ignore the rest.

Editorial standards

  • Sourcing. Every factual claim is attributed inline. We distinguish between primary sources — regulatory filings, official agency communications, company disclosures — and secondary reporting.
  • Epistemic register. Facts, interpretations, and forward-looking analysis are labelled distinctly. We use hedge language when evidence is incomplete; we do not invent figures or extrapolate from absence.
  • Legal sensitivity. Unresolved litigation, investigations, and regulatory proceedings are described with qualifying language until they reach a final determination.
  • Counterpoint. Every analysis includes the strongest opposing reading. This is editorial discipline, not disclaimer.
  • Corrections. Material errors are corrected with a dated note at the foot of the affected piece. Send corrections to editor@healthsignals.news.
  • Independence. HealthSignals accepts no payment for editorial coverage. Sponsored content, when present, is labelled.

How we work

HealthSignals uses a structured editorial pipeline that combines original signal selection from regulatory sources, AI-assisted drafting under explicit editorial constraints, and human editorial review. The pipeline is built around six operating principles: source attribution, separation of fact from interpretation, legal sensitivity, anti-repetition across pieces, fact-canonicalisation between article body and visualisations, and signal-level dedupe across publications.

We publish multiple briefings per day rather than long-cycle features. Each piece is structured to be read in five to eight minutes and to surface (a) the structural stake, (b) the operational implication for payers and manufacturers, (c) the counterargument, and (d) the next decision point worth tracking.

Masthead

Fernando Pafumi, Founder, CEO & Editor

Fernando Pafumi founded HealthSignals in 2026 after more than 25 years in global business development and advisory roles, most recently at The Economist Group. He is based in Miami and works in English, Spanish and Portuguese. editor@healthsignals.news ·

HealthSignals (healthsignals.news) is not affiliated with HealthSignals, LLC of Pennsylvania.

Contact

Editorial: editor@healthsignals.news
Corrections: editor@healthsignals.news
Tips: tips@healthsignals.news


HealthSignals is published by HEALTHSIGNALS LLC, Miami, Florida. © 2026 HealthSignals. All rights reserved.